These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29242761)

  • 1. Insights in Public Health: Reframing Hepatitis C: Lessons in Successful Public Health Collaboration.
    Pham T; Wasserman GM
    Hawaii J Med Public Health; 2017 Dec; 76(12):346-349. PubMed ID: 29242761
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs.
    Grebely J; Bruggmann P; Treloar C; Byrne J; Rhodes T; Dore GJ;
    Int J Drug Policy; 2015 Oct; 26(10):893-8. PubMed ID: 26254497
    [No Abstract]   [Full Text] [Related]  

  • 3. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C infection among injecting drug users in Scotland: stemming the flow.
    Goldberg D; Taylor A; Hutchinson S; McMenamin J
    Scott Med J; 2000 Oct; 45(5):131-2. PubMed ID: 11130293
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M; Reimer J; Meyer K; Gerlach JT; Zachoval R
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prisoners who inject drugs: public health and human rights imperatives.
    Jürgens R; Betteridge G
    Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral hepatitis B and C: an object of public health research].
    Desenclos JC; Delfraissy JF
    Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S1-1S3. PubMed ID: 17073124
    [No Abstract]   [Full Text] [Related]  

  • 8. Injecting drug use in India and the need for policy and program change.
    Panda S; Kumar MS
    Int J Drug Policy; 2016 Nov; 37():115-116. PubMed ID: 27771524
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
    Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
    Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biases in surveillance of hepatitis C infection systematically underestimate the etiologic role of tattooing.
    Fischer RP; Haley RW
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1222-3. PubMed ID: 15377309
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C: waiting for the grim reaper.
    Wodak A
    Med J Aust; 1997 Mar; 166(6):284-5. PubMed ID: 9087180
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection and substance abuse: medical management and developing models of integrated care--an introduction.
    Kresina TF; Khalsa J; Cesari H; Francis H
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S259-62. PubMed ID: 15768332
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?
    Mumtaz GR; Weiss HA; Abu-Raddad LJ
    J Int AIDS Soc; 2015; 18(1):20582. PubMed ID: 26221872
    [No Abstract]   [Full Text] [Related]  

  • 14. Harm reduction: closing the distance.
    CMAJ; 2001 Aug; 165(4):389, 391. PubMed ID: 11531042
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modifications of epidemiological characteristics of hepatitis C].
    Roudot-Thoraval F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B138-43. PubMed ID: 12180281
    [No Abstract]   [Full Text] [Related]  

  • 16. Tackling hepatitis C: a tale of two countries.
    Morris K
    Lancet; 2011 Apr; 377(9773):1227-8. PubMed ID: 21495219
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe.
    Kautz A; Chavdarova L; Walker M
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S3. PubMed ID: 25253094
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C and drug dependence].
    Monnat M; Forel P
    Rev Med Suisse Romande; 1998 Sep; 118(9):755-6. PubMed ID: 9810187
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of hepatitis C. How to update the pioneer work done by Eugène Jamot?].
    Coton T
    Presse Med; 2003 Sep; 32(29):1349-50. PubMed ID: 14534495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.